AMMF Cholangiocarcinoma Conference 2019
08 – 10 May 2019
AMMF’s conference is dedicated exclusively to cholangiocarcinoma (bile duct cancer) – with international speakers presenting what’s new in treatments and clinical trials, updates on the cholangiocarcinoma research that AMMF is supporting, and more. Plus, there will be plenty of time for networking and one to one conversations with world-class specialists.
Who should attend?
This conference is for everyone with an interest in cholangiocarcinoma, including:
- Scientists and researchers
- Nurse specialists
- Pharmaceutical companies
- Patients, their families and friends
- AMMF’s supporters and fundraisers
AMMF’s Cholangiocarcinoma Conference is
a BASL endorsed event.
AMMF’s Cholangiocarcinoma Conference is CPD accredited. A CPD Certificate of Attendance (attendance equals 6 hrs CPD) will be issued to delegates requesting one. This will enable them to record their attendance towards their formal CPD requirements for their professional body, institute or employer.
The Conference Programme
For the full 2019 programme, click here
Is there a fee to attend the conference?
AMMF is not making a charge for professional medical delegates (including Clinical Nurse Specialists), and patients/carers/family members to attend the conference.
I would like to attend the conference – do I need to register?
Yes, you must register if you wish to attend the conference. Full details on the conference, the venue and how to register are on AMMF’s Conference event page on the Eventbrite site – just click here.
Call for Abstracts
There will be a poster exhibition at AMMF’s CCA Conference on Thursday 09 May.
Abstracts showing an original paper/trial, audit, case study or a professional experience will be accepted.
Call for Abstracts deadline: 31st March, 2019
For information on abstract submission, click here.
To see the available conference sponsorship opportunities, click here.
How can I find out more?
Full information and FAQs can be seen by clicking here.
For AMMF’s 2018 Conference, click here.